Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study

Fatemeh Saberi Hosnijeh*, Lina van der Straten, Arnon P. Kater, Marinus H. J. van Oers, Ward F. M. Posthuma, Martine E. D. Chamuleau, Mar Bellido, Jeanette K. Doorduijn, Michel van Gelder, Mels Hoogendoorn, Fransien de Boer, G. Doreen te Raa, J. Martijn Kerst, Erik W. A. Marijt, Reinier A. P. Raymakers, Harry R. Koene, Martijn R. Schaafsma, Johan A. Dobber, Sanne H. Tonino, Sabina S. KerstingAnton W. Langerak, Mark-David Levin

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study'. Together they form a unique fingerprint.

Keyphrases

INIS

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology